http://www.renub.com/report/global-diabetes-market-trends-future-forecast---diabetes-drug-anti-diabetic-drug-insulin-dpp-iv-glp-1-27 Renub Research has announced the addition of "Global Diabetes Market Trends & Future Forecast – Diabetes Drug (Anti-Diabetic Drug), Insulin, DPP-IV, GLP-1" report to its offering Click here to view the report details: http://www.renub.com/report/global-diabetes-market-trends-future-forecast---diabetes-drug-anti-diabetic-drug-insulin-dpp-iv-glp-1-27 For more information visit: http://www.renub.com/ Contact Us Ankit Mishra Relationship Manager Sales & Marketing Div Renub Research Email: info@renub.com Phone: +1-678-302-0700 (USA) +91-120-254-5750 (India) Web: http://www.renub.com/ About US: Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others

1. Publisher: Renub Research
Published: June 2010

2. © Renub Research Page 2 of 10
Report Details
“Global Diabetes Market Trends & Future Forecast – Diabetes Drug (Anti-Diabetic Drug),
Insulin, DPP-IV, GLP-1” report published by Renub Research provides an in-depth analysis of
the past, present and future prospects. The report has been researched at source globally,
country specific and features latest available data covering:
 Global Diabetes Drug, Insulin, DPP-IV, GLP-1 Agonists Market and Future Forecast
 Region wise Diabetes, Impaired Glucose Tolerance (IGT) Population and Prevalence
 Region wise Diabetes Health Expenditure and Mortality
 Top 10 Countries Diabetes Population and Future Forecast
 Top 5 Countries Diabetes Drug Market and Future Forecast
 Top 7 Countries Insulin Market and Future Forecast
 Top 6 Diabetes Drug Brands (Avandia, Actos, Amaryl, Avandamet, Prandin/Novonorm,
Starlix) data of Past, Present and Future Market
 Top 9 Insulin Brands (Novomix, Novorapid, Levemir, Degludec, Degludecplus, Humalog,
Humulin, Apidra, Lantus) data of Past, Present and Future Market
 Top 4 DPP-IV Inhibitors (Januvia, Onglyza, Alogliptin, Galvus) data of Past,
Present and Future Market
 Top 5 GLP-1 Agonists (Byetta, Victoza, Exenatide LAR, Syncria, Taspoglutide) data of
Past, Present and Future Market
Research Highlights
 USA controls more than 50% of the total Diabetes Drug market share in 2009
 Global Insulin Market is estimated to reach around US$ 17 Billion by 2013
 China will have the second highest Insulin market share by 2012 replacing Germany
 DPP-IV Inhibitors is predicted to be more than US$ 5 Billion market by 2015
 GLP-1 Agonists, market is forecasted to cross US$ 6 Billion mark by 2015
 Novorapid is the blockbuster Insulin of Novo Nordisk it is expected to cross US$ 3
Billion by 2015.

3. © Renub Research Page 3 of 10
 Yet to launched Degludec and DegludecPlus is expected to be blockbuster Insulin and
cross US$ 4 Billion and US$ 6 Billion respectively by 2030.
 Januvia is proving a blockbuster of DPP – IV Inhibitors segment expected to be more
than US$ 4 Billion by 2017
 Last year launched Victoza and yet to be launched Exenatide LAR is going to be
blockbuster GLP-1 Agonists
 China diabetes drug market has crossed the figure of Yuan 10 Billion by 2009
 Japan Insulin market is expected to be more than US$ 1 Billion by 2010
Key Drugs Analyzed
Diabetes Drug: Avandia, Actos, Amaryl, Avandamet, Prandin/Novonorm, Starlix
Insulin: Novomix, Novorapid, Levemir, Degludec, Degludecplus, Humalog, Humulin, Apidra,
Lantus
DPP-IV Inhibitors: Januvia, Onglyza, Alogliptin, Galvus,
GLP-1 Agonists: Byetta, Victoza, Exenatide LAR, Syncria, Taspoglutide
Data Sources
Information and data in this report has been collected from various printable and non-
printable sources like Trade Journals, White papers, Online paid databases, News websites,
Government Agencies, Magazines, Newspapers and Trade associations.

4. © Renub Research Page 4 of 10
Table of Contents
1. Executive Summary
2. Global Diabetes Market
2.1 Global – Diabetes Drug Market & Future Forecast
2.2 Global – Insulin Market & Future Forecast
2.3 Global – Diabetes Drug Market Share & Future Forecast of (Brazil, China, Japan, USA, India)
2.4 Global – Insulin Market Share & Future Forecast of (Mexico, Germany, Russia, China, Japan,
USA, India)
2.5 Global – Dipeptidyl Peptidase (DPP – IV) Inhibitors Market & Future Forecast
2.6 Global – Glucagon-like Peptide-1(GLP-1) Market & Future Forecast
3. Global – Top 6 Diabetes Drug Brands Market Performance
3.1 Avandia – Past & Present Market
3.2 Actos – Past, Present & Future Forecast
3.3 Amaryl – Past, Present & Future Forecast
3.4 Avandamet – Past, Present & Future Forecast
3.5 Prandin/Novonorm – Past & Present Market
3.6 Starlix – Past, Present & Future Forecast
4. Global – Top 9 Insulin Brands Market Performance
4.1 Novomix – Past, Present & Future Forecast
4.2 Novorapid – Past, Present & Future Forecast
4.3 Levemir – Past, Present & Future Forecast
4.4 Degludec – Yet to be Launched - Future Forecast
4.5 Degludecplus – Yet to be Launched – Future Forecast
4.6 Humalog – Past & Present Market
4.7 Humulin – Past & Present Market
4.8 Apidra – Past, Present & Future Forecast
4.9 Lantus – Past, Present & Future Forecast

5. © Renub Research Page 5 of 10
5. Global – DPP-IV Inhibitors Brands Market Performance
5.1 Januvia – Past, Present & Future Forecast
5.2 Onglyza – Past, Present & Future Forecast
5.3 Alogliptin – Yet to be Launched – Future Forecast
5.4 Galvus – Past, Present & Future Forecast
5.5 DPP-IV Inhibitors – In Trial Phases
6. Global – GLP-1 Agonists Brands Market Performance
6.1 Byetta – Past, Present & Future Forecast
6.2 Victoza – Past, Present & Future Forecast
6.3 Exenatide LAR – Yet to be Launched – Future Forecast
6.4 Syncria – Yet to be Launched – Future Forecast
6.5 Taspoglutide – Yet to be Launched – Future Forecast
7. Regional Estimates for Diabetes
7.1 Diabetes – Population & Prevalence
7.2 Impaired Glucose Tolerance (IGT) – Population & Prevalence
7.3 Mortality – Due to Diabetes
7.4 North America & Caribbean Region
7.4.1 Diabetes & Impaired Glucose Tolerance (IGT) – Population & Prevalence
7.4.2 Healthcare Expenditure & Type 1 Diabetes
7.4.3 Mortality
7.5 Middle East and North African Region
7.5.1 Diabetes & Impaired Glucose Tolerance (IGT) – Population & Prevalence
7.5.2 Healthcare Expenditure & Type 1 Diabetes
7.5.3 Mortality
7.6 South-East Asian Region
7.6.1 Diabetes & Impaired Glucose Tolerance (IGT) – Population & Prevalence
7.6.2 Healthcare Expenditure & Type 1 Diabetes
7.6.3 Mortality
7.7 European Region
7.7.1 Diabetes & Impaired Glucose Tolerance (IGT) – Population & Prevalence
7.7.2 Healthcare Expenditures & Type 1 Diabetes

6. © Renub Research Page 6 of 10
7.7.3 Mortality
7.8 South and Central American Region
7.8.1 Diabetes & Impaired Glucose Tolerance (IGT) – Population & Prevalence
7.8.2 Healthcare Expenditures & Type 1 Diabetes
7.8.3 Mortality
7.9 Western Pacific Region
7.9.1 Diabetes & Impaired Glucose Tolerance (IGT) – Population & Prevalence
7.9.2 Healthcare Expenditures & Type 1 Diabetes
7.9.3 Mortality
7.10 African Region
7.10.1 Diabetes & Impaired Glucose Tolerance (IGT) – Population & Prevalence
7.10.2 Healthcare Expenditure & Type 1 Diabetes
7.10.3 Mortality
8. Global – Top 10 Diabetic Countries Performance
8.1 Number of People in Top 10 Diabetic Place
8.2 Prevalence of Diabetes in Top 10 Countries
8.3 India
8.3.1 Diabetes Population & Future Scenario
8.3.2 India – Diabetes Drug Market & Future Forecast
8.3.3 India-Insulin Market & Future Forecast
8.4 China
8.4.1 Diabetes Population & Future Scenario
8.4.2 Diabetes Drug Market & Future Forecast
8.4.3 China Insulin Market & Future Forecast
8.5 United States
8.5.1 Diabetes Population & Future Scenario
8.5.2 Diabetes Drug Market & Future Forecast
8.5.3 Insulin Market & Future Forecast
8.6 Brazil
8.6.1 Diabetes Population & Future Scenario
8.6.2 Diabetes Drug Market & Future Forecast
8.7 Russia
8.7.1 Diabetes Population & Future Scenario
8.7.2 Insulin Market & Future Forecast

7. © Renub Research Page 7 of 10
8.8 Japan
8.8.1 Diabetes Population & Future Scenario
8.8.2 Diabetes Drug Market & Future Forecast
8.8.3 Insulin Market & Future Forecast
8.9 Germany
8.9.1 Diabetes Population & Future Scenario
8.9.2 Insulin Market & Future Forecast
8.10 Mexico
8.10.1 Diabetes Population & Future Scenario
8.10.2 Insulin Market & Future Forecast
8.11 Indonesia
8.11.1 Diabetes Population & Future Scenario
8.12 Pakistan
8.12.1 Diabetes Population & Future Scenario

8. © Renub Research Page 8 of 10
Order Form
Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact
Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780
Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to
info@renub.com
Format
Report Title: Global Diabetes Market Trends & Future Forecast – Diabetes Drug (Anti-Diabetic
Drug), Insulin, DPP-IV, GLP-1
Single User
(Email from Publisher)
Hard Copy
(Mail Delivery)
CD – Rom
(Mail Delivery)
Global Site License
(Multiple User License)
US$ 1,100 US$ 1,250 US$ 1,250 US$ 1,600
For ordering this report: Three easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.):
http://www.renub.com/report/global-diabetes-market-trends-future-forecast---diabetes-
drug-anti-diabetic-drug-insulin-dpp-iv-glp-1-27
2) Order by Wire Transfer:
http://www.renub.com/report/wiretransfer.aspx?id=27&pid=1092
To pay by Wire Transfer, please, fill in your contact details in the form below:

9. © Renub Research Page 9 of 10
Bank Details
Account Name: Renub Research
A/C No.: 109102000023296
Name of Bank: IDBI Bank Ltd.
Swift Code: IBKLINBB010
Bank Address: 4th
Floor
Indian Red Cross Building
1 Red Cross Road
Opposite Parliament Street
New Delhi – 110001
India
Contact Information
First Name: Last Name:
Email:
Job Title:
Company:
Address:
City:
Postal/Zip Code:
Country:
Phone:
Mobile:
Fax:
Report Format:
Your message:

10. © Renub Research Page 10 of 10
3) Order by Check
Please post the check accompanied by this form, to:
Company Address: Renub Research
1st
Floor
C-86, Sector -10
Noida - 201301
Uttar Pradesh
India
Phone: +91-120-4219-822, 4249-780
For free Sample copy report or to view any of our sample work please contact us at
info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)
Follow Us
Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090
LinkedIn: http://www.linkedin.com/company/renub-research
Twitter: http://twitter.com/RenubResearch